United Therapeutics Corp (NASDAQ:UTHR)
| 172.86 Delayed Data As of Jan 15 |  +5.60 / +3.35%Today’s Change | 75.58 Today|||52-Week Range 173.72 | +13.88% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 1.5B | 1.6B | 1.7B | 1.6B | |
| Cost of Goods Sold | 36.1M | 41.1M | 74.7M | 162.8M | ||
| Depreciation And Amortization | 32.9M | 31.6M | 31.0M | 35.9M | ||
| Operating Expenses | Gross Income | 1.4B | 1.5B | 1.6B | 1.4B | |
| General Expenses | 697.7M | 464.4M | 594.7M | 618.3M | ||
| Research And Development | 245.1M | 147.6M | 264.6M | 357.9M | ||
| Total Operating Expenses | 766.7M | 537.1M | 700.4M | 817.0M | ||
| Non-Operating Expenses | Operating Income | 699.0M | 1.1B | 1.0B | 810.8M | |
| Extraordinary Charge | 0.00 | 0.00 | -259.6M | -58.9M | ||
| Interest Expense On Debt | 4.7M | 3.9M | 9.0M | 13.9M | ||
| Other Expenses | 350.2M | 2.4M | 13.2M | -7.7M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 1.0B | 1.1B | 769.5M | 758.9M | |
| Income Taxes | -392.8M | -346.5M | -351.6M | -169.7M | ||
| Net Income | 651.6M | 713.7M | 417.9M | 589.2M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 46.0M | 43.8M | 44.0M | 43.5M | |
| Shares To Calculate EPS Diluted | 51.2M | 46.8M | 44.9M | 44.0M | ||
| Earnings Per Share | EPS | $12.72 | $15.25 | $9.31 | $13.39 | |
| EPS Diluted | $12.72 | $15.25 | $9.31 | $13.39 | ||
